Please enable JavaScript to continue using this application.

Compare $APLM vs $BOLD | Chartloom

Compare

$APLM vs $BOLD

Apollomics Inc · Boundless Bio Inc

APLM

Apollomics Inc

BOLD

Boundless Bio Inc

Compare $APLM vs $BOLD

Comparing Apollomics Inc and Boundless Bio Inc

APLMApollomics Inc

BOLDBoundless Bio Inc

APLMApollomics Inc

Market cap

$47M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

11.4%

52W performance

413.1%

FCF yield

-1.7%

BOLDBoundless Bio Inc

Market cap

$57M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

107.4%

52W performance

94.6%

FCF yield

-99.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

APLM

BOLD

Detailed metrics comparison

APLM

Apollomics Inc

BOLD

Boundless Bio Inc

Market Cap

APLM$47M

BOLD$57M

Enterprise Value

APLM$47M

BOLD$37M

Price

APLM$21.50

BOLD$2.53

P/E Ratio

APLMN/A

BOLDN/A

P/S Ratio

APLM0.00x

BOLD0.00x

EV/Sales

APLM0.00x

BOLD0.00x

EV/EBITDA

APLM0.00x

BOLD0.00x

P/B Ratio

APLM13.94x

BOLD0.90x

P/FCF Ratio

APLMN/A

BOLDN/A

EV/FCF

APLM-57.95x

BOLD-0.65x

PEG Ratio

APLMN/A

BOLDN/A

Forward P/E (NTM)

APLMN/A

BOLDN/A

Forward P/S (NTM)

APLMN/A

BOLDN/A

Revenue (TTM)

APLM$0

BOLD$0

Revenue Growth (YoY)

APLMN/A

BOLDN/A

Forward Rev Growth

APLM0.0%

BOLD0.0%

Gross Margin (TTM)

APLM0.0%

BOLD0.0%

Operating Margin (TTM)

APLM0.0%

BOLD0.0%

EBITDA Margin (TTM)

APLM0.0%

BOLD0.0%

Net Margin (TTM)

APLM0.0%

BOLD0.0%

FCF Margin (TTM)

APLMN/A

BOLDN/A

Net Income (TTM)

APLM$-823K

BOLD$-64M

FCF (TTM)

APLM$-814K

BOLD$-57M

EPS (TTM)

APLM-$0.06

BOLD-$2.85

ROE (TTM)

APLM-69339.0%

BOLD-7089.0%

ROA (TTM)

APLM-26328.0%

BOLD-4737.0%

ROIC (TTM)

APLM-56760.0%

BOLD-7089.0%

Cash

APLM$134K

BOLD$20M

Debt

APLM$0

BOLD$0

Net Cash/Debt

APLM$134K

BOLD$20M

Current Ratio (TTM)

APLM0.96x

BOLD9.48x

Quick Ratio (TTM)

APLM0.88x

BOLD9.35x

Debt/Equity (TTM)

APLM0.20x

BOLD0.00x

Debt/Assets (TTM)

APLM0.0%

BOLD0.0%

Interest Coverage (TTM)

APLMN/A

BOLDN/A

Net Debt/EBITDA (TTM)

APLM0.00x

BOLD0.00x

Beta

APLM1.37

BOLD0.44

52W Performance

APLM413.1%

BOLD94.6%

YTD Performance

APLM11.4%

BOLD107.4%

% from 52W High

APLM-49.0%

BOLD-20.0%

% from 52W Low

APLM410.7%

BOLD163.2%

Asset Turnover (TTM)

APLM0.00x

BOLD0.00x

FCF Yield (TTM)

APLM-1.7%

BOLD-99.8%

Earnings Yield (TTM)

APLM-1.7%

BOLD-112.6%

Dividend Yield (TTM)

APLMN/A

BOLDN/A

Rule of 40

APLM0.0

BOLD0.0

EV/GP/RG

APLMN/A

BOLDN/A

Ticker research

View APLM research View BOLD research

Metric	APLM Apollomics Inc	BOLD Boundless Bio Inc
Market & Valuation
Market Cap	$47M	$57M
Enterprise Value	$47M	$37M
Price	$21.50	$2.53
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	13.94x	0.90x
P/FCF Ratio	N/A	N/A
EV/FCF	-57.95x	-0.65x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-823K	$-64M
FCF (TTM)	$-814K	$-57M
EPS (TTM)	-$0.06	-$2.85
ROE (TTM)	-69339.0%	-7089.0%
ROA (TTM)	-26328.0%	-4737.0%
ROIC (TTM)	-56760.0%	-7089.0%
Financial Health
Cash	$134K	$20M
Debt	$0	$0
Net Cash/Debt	$134K	$20M
Current Ratio (TTM)	0.96x	9.48x
Quick Ratio (TTM)	0.88x	9.35x
Debt/Equity (TTM)	0.20x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.37	0.44
52W Performance	413.1%	94.6%
YTD Performance	11.4%	107.4%
% from 52W High	-49.0%	-20.0%
% from 52W Low	410.7%	163.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-1.7%	-99.8%
Earnings Yield (TTM)	-1.7%	-112.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View APLM research	View BOLD research

Valuation

P/S Ratio

APLM

0.00x

BOLD

0.00x

EV/FCF

APLM

-57.95x

BOLD

-0.65x

Growth & revenue

Forward Revenue Growth

APLM

0.0%

BOLD

0.0%

Profitability & performance

Gross Margin

APLM

0.0%

BOLD

0.0%

ROE

BOLD

-7089.0%

APLM

-69339.0%

FCF Yield %

APLM

-1.7%

BOLD

-99.8%

52-Week Performance

APLM

413.1%

BOLD

94.6%

Detailed metrics comparison

APLM

Apollomics Inc

BOLD

Boundless Bio Inc

Market Cap

APLM$47M

BOLD$57M

Enterprise Value

APLM$47M

BOLD$37M

Price

APLM$21.50

BOLD$2.53

P/E Ratio

APLMN/A

BOLDN/A

P/S Ratio

APLM0.00x

BOLD0.00x

EV/Sales

APLM0.00x

BOLD0.00x

EV/EBITDA

APLM0.00x

BOLD0.00x

P/B Ratio

APLM13.94x

BOLD0.90x

P/FCF Ratio

APLMN/A

BOLDN/A

EV/FCF

APLM-57.95x

BOLD-0.65x

PEG Ratio

APLMN/A

BOLDN/A

Forward P/E (NTM)

APLMN/A

BOLDN/A

Forward P/S (NTM)

APLMN/A

BOLDN/A

Revenue (TTM)

APLM$0

BOLD$0

Revenue Growth (YoY)

APLMN/A

BOLDN/A

Forward Rev Growth

APLM0.0%

BOLD0.0%

Gross Margin (TTM)

APLM0.0%

BOLD0.0%

Operating Margin (TTM)

APLM0.0%

BOLD0.0%

EBITDA Margin (TTM)

APLM0.0%

BOLD0.0%

Net Margin (TTM)

APLM0.0%

BOLD0.0%

FCF Margin (TTM)

APLMN/A

BOLDN/A

Net Income (TTM)

APLM$-823K

BOLD$-64M

FCF (TTM)

APLM$-814K

BOLD$-57M

EPS (TTM)

APLM-$0.06

BOLD-$2.85

ROE (TTM)

APLM-69339.0%

BOLD-7089.0%

ROA (TTM)

APLM-26328.0%

BOLD-4737.0%

ROIC (TTM)

APLM-56760.0%

BOLD-7089.0%

Cash

APLM$134K

BOLD$20M

Debt

APLM$0

BOLD$0

Net Cash/Debt

APLM$134K

BOLD$20M

Current Ratio (TTM)

APLM0.96x

BOLD9.48x

Quick Ratio (TTM)

APLM0.88x

BOLD9.35x

Debt/Equity (TTM)

APLM0.20x

BOLD0.00x

Debt/Assets (TTM)

APLM0.0%

BOLD0.0%

Interest Coverage (TTM)

APLMN/A

BOLDN/A

Net Debt/EBITDA (TTM)

APLM0.00x

BOLD0.00x

Beta

APLM1.37

BOLD0.44

52W Performance

APLM413.1%

BOLD94.6%

YTD Performance

APLM11.4%

BOLD107.4%

% from 52W High

APLM-49.0%

BOLD-20.0%

% from 52W Low

APLM410.7%

BOLD163.2%

Asset Turnover (TTM)

APLM0.00x

BOLD0.00x

FCF Yield (TTM)

APLM-1.7%

BOLD-99.8%

Earnings Yield (TTM)

APLM-1.7%

BOLD-112.6%

Dividend Yield (TTM)

APLMN/A

BOLDN/A

Rule of 40

APLM0.0

BOLD0.0

EV/GP/RG

APLMN/A

BOLDN/A

Ticker research

View APLM research View BOLD research

Metric	APLM Apollomics Inc	BOLD Boundless Bio Inc
Market & Valuation
Market Cap	$47M	$57M
Enterprise Value	$47M	$37M
Price	$21.50	$2.53
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	13.94x	0.90x
P/FCF Ratio	N/A	N/A
EV/FCF	-57.95x	-0.65x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-823K	$-64M
FCF (TTM)	$-814K	$-57M
EPS (TTM)	-$0.06	-$2.85
ROE (TTM)	-69339.0%	-7089.0%
ROA (TTM)	-26328.0%	-4737.0%
ROIC (TTM)	-56760.0%	-7089.0%
Financial Health
Cash	$134K	$20M
Debt	$0	$0
Net Cash/Debt	$134K	$20M
Current Ratio (TTM)	0.96x	9.48x
Quick Ratio (TTM)	0.88x	9.35x
Debt/Equity (TTM)	0.20x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.37	0.44
52W Performance	413.1%	94.6%
YTD Performance	11.4%	107.4%
% from 52W High	-49.0%	-20.0%
% from 52W Low	410.7%	163.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-1.7%	-99.8%
Earnings Yield (TTM)	-1.7%	-112.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View APLM research	View BOLD research